img

Global Model Organism Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Model Organism Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

A model organism is a species that has been widely studied, usually because it is easy to maintain and breed in a laboratory setting and has particular experimental advantages. Model organisms are non-human species that are used in the laboratory to help scientists understand biological processes.
Model Organism report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Model Organism market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Drug Discovery and Basic Research are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Model Organism industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Model Organism key companies include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories and Crown Biosciences, etc. Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories are top 3 players and held % share in total in 2023.
Model Organism can be divided into Prokaryote and Eukaryote, etc. Prokaryote is the mainstream product in the market, accounting for % share globally in 2023.
Model Organism is widely used in various fields, such as Drug Discovery, Basic Research, Toxicity Test and Parasitological Study, etc. Drug Discovery provides greatest supports to the Model Organism industry development. In 2023, global % share of Model Organism went into Drug Discovery filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Model Organism market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
Segment by Type
Prokaryote
Eukaryote

Segment by Application


Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Model Organism market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Model Organism introduction, etc. Model Organism Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Model Organism market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Market Overview of Model Organism
1.1 Model Organism Market Overview
1.1.1 Model Organism Product Scope
1.1.2 Model Organism Market Status and Outlook
1.2 Global Model Organism Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global Model Organism Market Size by Region (2018-2033)
1.4 Global Model Organism Historic Market Size by Region (2018-2023)
1.5 Global Model Organism Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Model Organism Market Size (2018-2033)
1.6.1 North America Model Organism Market Size (2018-2033)
1.6.2 Europe Model Organism Market Size (2018-2033)
1.6.3 Asia-Pacific Model Organism Market Size (2018-2033)
1.6.4 Latin America Model Organism Market Size (2018-2033)
1.6.5 Middle East & Africa Model Organism Market Size (2018-2033)
2 Model Organism Market by Type
2.1 Introduction
2.1.1 Prokaryote
2.1.2 Eukaryote
2.2 Global Model Organism Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global Model Organism Historic Market Size by Type (2018-2023)
2.2.2 Global Model Organism Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Model Organism Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Model Organism Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Model Organism Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Model Organism Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Model Organism Revenue Breakdown by Type (2018-2033)
3 Model Organism Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery
3.1.2 Basic Research
3.1.3 Toxicity Test
3.1.4 Parasitological Study
3.1.5 Hereditary Disease Study
3.1.6 Others
3.2 Global Model Organism Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global Model Organism Historic Market Size by Application (2018-2023)
3.2.2 Global Model Organism Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Model Organism Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Model Organism Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Model Organism Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Model Organism Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Model Organism Revenue Breakdown by Application (2018-2033)
4 Model Organism Competition Analysis by Players
4.1 Global Model Organism Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Model Organism as of 2023)
4.3 Date of Key Players Enter into Model Organism Market
4.4 Global Top Players Model Organism Headquarters and Area Served
4.5 Key Players Model Organism Product Solution and Service
4.6 Competitive Status
4.6.1 Model Organism Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Shanghai Model Organisms Center, Inc.
5.1.1 Shanghai Model Organisms Center, Inc. Profile
5.1.2 Shanghai Model Organisms Center, Inc. Main Business
5.1.3 Shanghai Model Organisms Center, Inc. Model Organism Products, Services and Solutions
5.1.4 Shanghai Model Organisms Center, Inc. Model Organism Revenue (US$ Million) & (2018-2023)
5.1.5 Shanghai Model Organisms Center, Inc. Recent Developments
5.2 Gem Pharmatech Co., Ltd.
5.2.1 Gem Pharmatech Co., Ltd. Profile
5.2.2 Gem Pharmatech Co., Ltd. Main Business
5.2.3 Gem Pharmatech Co., Ltd. Model Organism Products, Services and Solutions
5.2.4 Gem Pharmatech Co., Ltd. Model Organism Revenue (US$ Million) & (2018-2023)
5.2.5 Gem Pharmatech Co., Ltd. Recent Developments
5.3 Charles River Laboratories
5.3.1 Charles River Laboratories Profile
5.3.2 Charles River Laboratories Main Business
5.3.3 Charles River Laboratories Model Organism Products, Services and Solutions
5.3.4 Charles River Laboratories Model Organism Revenue (US$ Million) & (2018-2023)
5.3.5 Envigo Recent Developments
5.4 Envigo
5.4.1 Envigo Profile
5.4.2 Envigo Main Business
5.4.3 Envigo Model Organism Products, Services and Solutions
5.4.4 Envigo Model Organism Revenue (US$ Million) & (2018-2023)
5.4.5 Envigo Recent Developments
5.5 Taconic Biosciences
5.5.1 Taconic Biosciences Profile
5.5.2 Taconic Biosciences Main Business
5.5.3 Taconic Biosciences Model Organism Products, Services and Solutions
5.5.4 Taconic Biosciences Model Organism Revenue (US$ Million) & (2018-2023)
5.5.5 Taconic Biosciences Recent Developments
5.6 Jackson Laboratory
5.6.1 Jackson Laboratory Profile
5.6.2 Jackson Laboratory Main Business
5.6.3 Jackson Laboratory Model Organism Products, Services and Solutions
5.6.4 Jackson Laboratory Model Organism Revenue (US$ Million) & (2018-2023)
5.6.5 Jackson Laboratory Recent Developments
5.7 Shanghai SLAC
5.7.1 Shanghai SLAC Profile
5.7.2 Shanghai SLAC Main Business
5.7.3 Shanghai SLAC Model Organism Products, Services and Solutions
5.7.4 Shanghai SLAC Model Organism Revenue (US$ Million) & (2018-2023)
5.7.5 Shanghai SLAC Recent Developments
5.8 Joinn Laboratories
5.8.1 Joinn Laboratories Profile
5.8.2 Joinn Laboratories Main Business
5.8.3 Joinn Laboratories Model Organism Products, Services and Solutions
5.8.4 Joinn Laboratories Model Organism Revenue (US$ Million) & (2018-2023)
5.8.5 Joinn Laboratories Recent Developments
5.9 Crown Biosciences
5.9.1 Crown Biosciences Profile
5.9.2 Crown Biosciences Main Business
5.9.3 Crown Biosciences Model Organism Products, Services and Solutions
5.9.4 Crown Biosciences Model Organism Revenue (US$ Million) & (2018-2023)
5.9.5 Crown Biosciences Recent Developments
5.10 Pharmalegacy
5.10.1 Pharmalegacy Profile
5.10.2 Pharmalegacy Main Business
5.10.3 Pharmalegacy Model Organism Products, Services and Solutions
5.10.4 Pharmalegacy Model Organism Revenue (US$ Million) & (2018-2023)
5.10.5 Pharmalegacy Recent Developments
5.11 Syngene International
5.11.1 Syngene International Profile
5.11.2 Syngene International Main Business
5.11.3 Syngene International Model Organism Products, Services and Solutions
5.11.4 Syngene International Model Organism Revenue (US$ Million) & (2018-2023)
5.11.5 Syngene International Recent Developments
5.12 Janvier Labs
5.12.1 Janvier Labs Profile
5.12.2 Janvier Labs Main Business
5.12.3 Janvier Labs Model Organism Products, Services and Solutions
5.12.4 Janvier Labs Model Organism Revenue (US$ Million) & (2018-2023)
5.12.5 Janvier Labs Recent Developments
5.13 GenOway
5.13.1 GenOway Profile
5.13.2 GenOway Main Business
5.13.3 GenOway Model Organism Products, Services and Solutions
5.13.4 GenOway Model Organism Revenue (US$ Million) & (2018-2023)
5.13.5 GenOway Recent Developments
5.14 Psychogenics
5.14.1 Psychogenics Profile
5.14.2 Psychogenics Main Business
5.14.3 Psychogenics Model Organism Products, Services and Solutions
5.14.4 Psychogenics Model Organism Revenue (US$ Million) & (2018-2023)
5.14.5 Psychogenics Recent Developments
5.15 Horizon Discovery Group
5.15.1 Horizon Discovery Group Profile
5.15.2 Horizon Discovery Group Main Business
5.15.3 Horizon Discovery Group Model Organism Products, Services and Solutions
5.15.4 Horizon Discovery Group Model Organism Revenue (US$ Million) & (2018-2023)
5.15.5 Horizon Discovery Group Recent Developments
5.16 Vitalstar Biotechnology
5.16.1 Vitalstar Biotechnology Profile
5.16.2 Vitalstar Biotechnology Main Business
5.16.3 Vitalstar Biotechnology Model Organism Products, Services and Solutions
5.16.4 Vitalstar Biotechnology Model Organism Revenue (US$ Million) & (2018-2023)
5.16.5 Vitalstar Biotechnology Recent Developments
6 North America
6.1 North America Model Organism Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Model Organism Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Model Organism Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Model Organism Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Model Organism Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Model Organism Market Dynamics
11.1 Model Organism Industry Trends
11.2 Model Organism Market Drivers
11.3 Model Organism Market Challenges
11.4 Model Organism Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Model Organism Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global Model Organism Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Model Organism Market Size Share by Region (2018-2023)
Table 4. Global Model Organism Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Model Organism Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Model Organism Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global Model Organism Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Model Organism Revenue Market Share by Type (2018-2023)
Table 9. Global Model Organism Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Model Organism Revenue Market Share by Type (2024-2033)
Table 11. North America Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Model Organism Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Model Organism Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Model Organism Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global Model Organism Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Model Organism Revenue Market Share by Application (2018-2023)
Table 24. Global Model Organism Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Model Organism Revenue Market Share by Application (2024-2033)
Table 26. North America Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Model Organism Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Model Organism Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Model Organism Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Model Organism Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Model Organism as of 2023)
Table 39. Date of Key Players Enter into Model Organism Market
Table 40. Global Model Organism Key Players Headquarters and Area Served
Table 41. Model Organism Product Solution and Service
Table 42. Global Model Organism Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Shanghai Model Organisms Center, Inc. Basic Information List
Table 45. Shanghai Model Organisms Center, Inc. Description and Business Overview
Table 46. Shanghai Model Organisms Center, Inc. Model Organism Products, Services and Solutions
Table 47. Revenue (US$ Million) in Model Organism Business of Shanghai Model Organisms Center, Inc. (2018-2023)
Table 48. Shanghai Model Organisms Center, Inc. Recent Developments
Table 49. Gem Pharmatech Co., Ltd. Basic Information List
Table 50. Gem Pharmatech Co., Ltd. Description and Business Overview
Table 51. Gem Pharmatech Co., Ltd. Model Organism Products, Services and Solutions
Table 52. Revenue (US$ Million) in Model Organism Business of Gem Pharmatech Co., Ltd. (2018-2023)
Table 53. Gem Pharmatech Co., Ltd. Recent Developments
Table 54. Charles River Laboratories Basic Information List
Table 55. Charles River Laboratories Description and Business Overview
Table 56. Charles River Laboratories Model Organism Products, Services and Solutions
Table 57. Revenue (US$ Million) in Model Organism Business of Charles River Laboratories (2018-2023)
Table 58. Charles River Laboratories Recent Developments
Table 59. Envigo Basic Information List
Table 60. Envigo Description and Business Overview
Table 61. Envigo Model Organism Products, Services and Solutions
Table 62. Revenue (US$ Million) in Model Organism Business of Envigo (2018-2023)
Table 63. Envigo Recent Developments
Table 64. Taconic Biosciences Basic Information List
Table 65. Taconic Biosciences Description and Business Overview
Table 66. Taconic Biosciences Model Organism Products, Services and Solutions
Table 67. Revenue (US$ Million) in Model Organism Business of Taconic Biosciences (2018-2023)
Table 68. Taconic Biosciences Recent Developments
Table 69. Jackson Laboratory Basic Information List
Table 70. Jackson Laboratory Description and Business Overview
Table 71. Jackson Laboratory Model Organism Products, Services and Solutions
Table 72. Revenue (US$ Million) in Model Organism Business of Jackson Laboratory (2018-2023)
Table 73. Jackson Laboratory Recent Developments
Table 74. Shanghai SLAC Basic Information List
Table 75. Shanghai SLAC Description and Business Overview
Table 76. Shanghai SLAC Model Organism Products, Services and Solutions
Table 77. Revenue (US$ Million) in Model Organism Business of Shanghai SLAC (2018-2023)
Table 78. Shanghai SLAC Recent Developments
Table 79. Joinn Laboratories Basic Information List
Table 80. Joinn Laboratories Description and Business Overview
Table 81. Joinn Laboratories Model Organism Products, Services and Solutions
Table 82. Revenue (US$ Million) in Model Organism Business of Joinn Laboratories (2018-2023)
Table 83. Joinn Laboratories Recent Developments
Table 84. Crown Biosciences Basic Information List
Table 85. Crown Biosciences Description and Business Overview
Table 86. Crown Biosciences Model Organism Products, Services and Solutions
Table 87. Revenue (US$ Million) in Model Organism Business of Crown Biosciences (2018-2023)
Table 88. Crown Biosciences Recent Developments
Table 89. Pharmalegacy Basic Information List
Table 90. Pharmalegacy Description and Business Overview
Table 91. Pharmalegacy Model Organism Products, Services and Solutions
Table 92. Revenue (US$ Million) in Model Organism Business of Pharmalegacy (2018-2023)
Table 93. Pharmalegacy Recent Developments
Table 94. Syngene International Basic Information List
Table 95. Syngene International Description and Business Overview
Table 96. Syngene International Model Organism Products, Services and Solutions
Table 97. Revenue (US$ Million) in Model Organism Business of Syngene International (2018-2023)
Table 98. Syngene International Recent Developments
Table 99. Janvier Labs Basic Information List
Table 100. Janvier Labs Description and Business Overview
Table 101. Janvier Labs Model Organism Products, Services and Solutions
Table 102. Revenue (US$ Million) in Model Organism Business of Janvier Labs (2018-2023)
Table 103. Janvier Labs Recent Developments
Table 104. GenOway Basic Information List
Table 105. GenOway Description and Business Overview
Table 106. GenOway Model Organism Products, Services and Solutions
Table 107. Revenue (US$ Million) in Model Organism Business of GenOway (2018-2023)
Table 108. GenOway Recent Developments
Table 109. Psychogenics Basic Information List
Table 110. Psychogenics Description and Business Overview
Table 111. Psychogenics Model Organism Products, Services and Solutions
Table 112. Revenue (US$ Million) in Model Organism Business of Psychogenics (2018-2023)
Table 113. Psychogenics Recent Developments
Table 114. Horizon Discovery Group Basic Information List
Table 115. Horizon Discovery Group Description and Business Overview
Table 116. Horizon Discovery Group Model Organism Products, Services and Solutions
Table 117. Revenue (US$ Million) in Model Organism Business of Horizon Discovery Group (2018-2023)
Table 118. Horizon Discovery Group Recent Developments
Table 119. Vitalstar Biotechnology Basic Information List
Table 120. Vitalstar Biotechnology Description and Business Overview
Table 121. Vitalstar Biotechnology Model Organism Products, Services and Solutions
Table 122. Revenue (US$ Million) in Model Organism Business of Vitalstar Biotechnology (2018-2023)
Table 123. Vitalstar Biotechnology Recent Developments
Table 124. North America Model Organism Market Size by Country (2018-2023) & (US$ Million)
Table 125. North America Model Organism Market Size by Country (2024-2033) & (US$ Million)
Table 126. Europe Model Organism Market Size by Country (2018-2023) & (US$ Million)
Table 127. Europe Model Organism Market Size by Country (2024-2033) & (US$ Million)
Table 128. Asia-Pacific Model Organism Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 129. Asia-Pacific Model Organism Market Size by Region (2018-2023) & (US$ Million)
Table 130. Asia-Pacific Model Organism Market Size by Region (2024-2033) & (US$ Million)
Table 131. Asia-Pacific Model Organism Market Share by Region (2018-2023)
Table 132. Asia-Pacific Model Organism Market Share by Region (2024-2033)
Table 133. Latin America Model Organism Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 134. Latin America Model Organism Market Size by Country (2018-2023) & (US$ Million)
Table 135. Latin America Model Organism Market Size by Country (2024-2033) & (US$ Million)
Table 136. Middle East & Africa Model Organism Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 137. Middle East & Africa Model Organism Market Size by Country (2018-2023) & (US$ Million)
Table 138. Middle East & Africa Model Organism Market Size by Country (2024-2033) & (US$ Million)
Table 139. Model Organism Market Trends
Table 140. Model Organism Market Drivers
Table 141. Model Organism Market Challenges
Table 142. Model Organism Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Model Organism Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Model Organism Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Model Organism Market Share by Regions: 2023 VS 2033
Figure 4. Global Model Organism Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Model Organism Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Model Organism Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Model Organism Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Model Organism Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Model Organism Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Prokaryote
Figure 11. Global Prokaryote Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Eukaryote
Figure 13. Global Eukaryote Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Model Organism Market Size Share by Type: 2023 & 2033
Figure 15. North America Model Organism Revenue Market Share by Type (2018-2033)
Figure 16. Europe Model Organism Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Model Organism Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Model Organism Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Model Organism Revenue Market Share by Type (2018-2033)
Figure 20. Drug Discovery Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Basic Research Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Toxicity Test Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Parasitological Study Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Hereditary Disease Study Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Global Model Organism Market Size Share by Application: 2023 & 2033
Figure 27. North America Model Organism Revenue Market Share by Application (2018-2033)
Figure 28. Europe Model Organism Revenue Market Share by Application (2018-2033)
Figure 29. Asia-Pacific Model Organism Revenue Market Share by Application (2018-2033)
Figure 30. Latin America Model Organism Revenue Market Share by Application (2018-2033)
Figure 31. Middle East and Africa Model Organism Revenue Market Share by Application (2018-2033)
Figure 32. Model Organism Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 33. Global Top 5 and Top 10 Players Model Organism Market Share in 2023
Figure 34. North America Model Organism Market Share by Country (2018-2033)
Figure 35. U.S. Model Organism Market Size (2018-2033) & (US$ Million)
Figure 36. Canada Model Organism Market Size (2018-2033) & (US$ Million)
Figure 37. Germany Model Organism Market Size (2018-2033) & (US$ Million)
Figure 38. France Model Organism Market Size (2018-2033) & (US$ Million)
Figure 39. U.K. Model Organism Market Size (2018-2033) & (US$ Million)
Figure 40. Italy Model Organism Market Size (2018-2033) & (US$ Million)
Figure 41. Russia Model Organism Market Size (2018-2033) & (US$ Million)
Figure 42. Nordic Countries Model Organism Market Size (2018-2033) & (US$ Million)
Figure 43. Asia-Pacific Model Organism Market Share by Region (2018-2033)
Figure 44. China Model Organism Market Size (2018-2033) & (US$ Million)
Figure 45. Japan Model Organism Market Size (2018-2033) & (US$ Million)
Figure 46. South Korea Model Organism Market Size (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Model Organism Market Size (2018-2033) & (US$ Million)
Figure 48. India Model Organism Market Size (2018-2033) & (US$ Million)
Figure 49. Australia Model Organism Market Size (2018-2033) & (US$ Million)
Figure 50. Latin America Model Organism Market Share by Country (2018-2033)
Figure 51. Mexico Model Organism Market Size (2018-2033) & (US$ Million)
Figure 52. Brazil Model Organism Market Size (2018-2033) & (US$ Million)
Figure 53. Middle East & Africa Model Organism Market Share by Country (2018-2033)
Figure 54. Turkey Model Organism Market Size (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Model Organism Market Size (2018-2033) & (US$ Million)
Figure 56. UAE Model Organism Market Size (2018-2033) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report